Elena Fisheleva

Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · The Lancet · 2020 · 198 citations

Medicine, Pediatrics, Pharmacotherapy +2

Design of the Tocilizumab in Giant Cell Arteritis Trial

Sebastian Unizony, Bhaskar Dasgupta, Elena Fisheleva et al. · International Journal of Rheumatology · 2013 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

Ravi Savarirayan, Louise Tofts, Melita Irving et al. · Genetics in Medicine · 2021 · 99 citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +10

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program

Paul Emery, William F. C. Rigby, Paul P. Tak et al. · PLoS ONE · 2014 · 81 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial

William F. C. Rigby, H-P Tony, Kurt Oelke et al. · Arthritis & Rheumatism · 2011 · 77 citations

Medicine, Pharmacology, Pharmacotherapy +13